Long-term followup of initial Ta grade 1 transitional cell carcinoma of the bladder

Journal of Urology

Volumn 162, Issue 6, 1999, Pages 1946-1950

  Leblanc, B ^a   Duclos, A J ^a   Benard F ^a   Cote J ^a   Valiquette, L ^a   Paquin, J M ^a   Mauffette, F ^a   Faucher, R ^a   Perreault, J P ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Bladder neoplasms; Carcinoma; Prognosis; Transitional cell

Indexed keywords

BCG VACCINE; MITOMYCIN C; THIOTEPA;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CARCINOMA IN SITU; CYSTOSCOPY; CYTOLOGY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

EID: 0032723015     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)68075-5     Document Type: Article

References (20)

1. Heney, N. M., Ahmed, S., Flanagan, M. J., Frable, W., Corder, M. P., Hafermann, M. D. and Hawkins, I. R. for National Bladder Cancer Collaborative Group A: Superficial bladder cancer: progression and recurrence. J. Urol., 130: 1083, 1983.
2. Lamm, D. L.: Long-term results of intravesical therapy for superficial bladder cancer. Urol. Clin. N. Amer., 19: 573, 1992.
3. Herr, H. W., Schwalb, D. M., Zhang, Z. F., Sogani, P. C., Fair, W. R., Whitmore, W. F., Jr. and Oettgen, H. F.: Intravesical bacillus Calmette-Guerin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial. J. Clin. Oncol., 13: 1404, 1995.
4. Morris, S. B., Gordon, E. M., Shearer, R. J. and Woodhouse, C. R.: Superficial bladder cancer: for how long should a tumor-free patient have check cystoscopies? Brit. J. Urol., 75: 193, 1995.
5. Cutler, S. J., Heney, N. M. and Friedell, G. H.: Longitudinal study of patients with bladder cancer: factors associated with disease recurrence and progression. In: Bladder Cancer. Edited by W. W. Bonney and G. R. Prout, Jr. Baltimore: Williams & Wilkins, pp. 35-46, 1982.
6. Dalesio, O., Schulman, C. C., Sylvester, R., De Pauw, M., Robinson, M., Denis, L., Smith, P. and Viggiano, G.: Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group. J. Urol., 129: 730, 1983.
7. Smith, G., Elton, R. A., Chisholm, G. D., Newsam, J. E. and Hargreave, T. B.: Superficial bladder cancer: intravesical chemotherapy and tumour progression to muscle invasion or metastases. Brit. J. Urol., 58: 659, 1986.
8. Parmar, M. K., Freedman, L. S., Hargreave, T. B. and Tolley, D. A.: Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). J. Urol., 142: 284, 1989.
9. Witjes, J. A., Kiemeney, L. A., Oosterhof, G. O. and Debruyne, F. M.: Prognostic factors in superficial bladder cancer. A review. Eur. Urol., 21: 89, 1992.
10. Bergkvist, A., Ljungqvist, A. and Moberger, G.: Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir. Scand., 130: 371, 1965.
11. Broders, A. C.: Epitheliomo of the genito-urinary organs. Ann. Surg., 75: 574, 1922.
12. Mostofi, F. K., Sobin, L. H. and Torloni, H.: Histological typing of urinary bladder tumours. International Histological Classification of Tumours, No. 10. Geneva: World Health Organization, 1973.
13. Abel, P. D.: Follow-up of patients with "superficial" transitional cell carcinoma of the bladder: the case for a change in policy. Brit. J. Urol., 72: 135, 1993.
14. Holmäng, S., Hedelin, H., Anderstrom, C. and Johansson, S. L.: The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J. Urol., 153: 1823, 1995.
15. Prout, G. R., Jr., Barton, B. A., Griffin, P. P. and Friedell, G. H.: Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group. J. Urol., 148: 1413, 1992.
16. Kalish, L. A., Garnick, M. B. and Richie, J. P.: Appropriate endpoints for superficial bladder cancer clinical trials. J. Clin. Oncol., 5: 2004, 1987.
17. Torti, F. M. and Lum, B. L.: The biology and treatment of superficial bladder cancer. J. Clin. Oncol., 2: 505, 1984.
18. Greene, L. F., Hanash, K. A. and Farrow, G. M.: Benign papilloma or papillary carcinoma of the bladder? J. Urol., 110: 205, 1973.
19. Greven, K. M., Spera, J. A., Solin, L. J., Hanks, G. E. and Morgan, T.: Local recurrence after cystectomy alone for bladder carcinoma. Cancer, 69: 2767, 1992.
20. Thompson, R. A., Jr., Campbell, E. W., Jr., Kramer, H. C., Jacobs, S. C. and Naslund, M. J.: Late invasive recurrence despite long-term surveillance for superficial bladder cancer. J. Urol., 149: 1010, 1993.